U.S. Capital Wealth Advisors’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,871
Closed -$1.08K 661
2022
Q4
$1.08K Buy
+1,871
New +$1.08K ﹤0.01% 1529